Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-12

Clinical Trial Update: Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating mifepristone after progestin priming for use as a 'missed period' pill.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Missed Menstrual Period | Phase 2 | Status: UNKNOWN